Paper41328409
Defect-complementation homologous recombination: A novel strategy for precise genome engineering of virulent phages.
Zhang H and 8 others. Synth Syst Biotechnol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Defect-complementation homologous recombination: A novel strategy for precise genome engineering of virulent phages. Papers, record 41328409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41328409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Defect-complementation homologous recombination: A novel strategy for precise genome engineering of virulent phages.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References50
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 9230304 | The translocating RecBCD enzyme stimulates recombination by directing RecA protein onto ssDNA in a chi-regulated manner. | Cell | 1997 | https://conductscience.org/library/papers/9230304 | PubMed |
| 2 | 19088849 | BRED: a simple and powerful tool for constructing mutant and recombinant bacteriophage genomes. | PLoS One | 2008 | https://conductscience.org/library/papers/19088849 | PubMed |
| 3 | 25313071 | Capsid expansion mechanism of bacteriophage T7 revealed by multistate atomic models derived from cryo-EM reconstructions. | Proc Natl Acad Sci U S A | 2014 | https://conductscience.org/library/papers/25313071 | PubMed |
| 4 | 29762716 | CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens. | Nucleic Acids Res | 2018 | https://conductscience.org/library/papers/29762716 | PubMed |
| 5 | 33001567 | Precision genome editing in plants via gene targeting and subsequent break-induced single-strand annealing. | Plant Biotechnol J | 2021 | https://conductscience.org/library/papers/33001567 | PubMed |
| 6 | 8919773 | Construction of luciferase reporter bacteriophage A511::luxAB for rapid and sensitive detection of viable Listeria cells. | Appl Environ Microbiol | 1996 | https://conductscience.org/library/papers/8919773 | PubMed |
| 7 | 23884409 | Structural characterization of the bacteriophage T7 tail machinery. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23884409 | PubMed |
| 8 | 28657724 | Engineering of Bacteriophage T4 Genome Using CRISPR-Cas9. | ACS Synth Biol | 2017 | https://conductscience.org/library/papers/28657724 | PubMed |
| 9 | 23982993 | Expanding the scope of site-specific recombinases for genetic and metabolic engineering. | Biotechnol Bioeng | 2014 | https://conductscience.org/library/papers/23982993 | PubMed |
| 10 | 26397828 | From Gene Targeting to Genome Editing: Transgenic animals applications and beyond. | An Acad Bras Cienc | 2015 | https://conductscience.org/library/papers/26397828 | PubMed |
| 11 | 39493338 | CRISPR/Cas12a-based genome editing for cyanophage of Anabeana sp. | Synth Syst Biotechnol | 2025 | https://conductscience.org/library/papers/39493338 | PubMed |
| 12 | 36712324 | Acylation driven by intracellular metabolites in host cells inhibits Cas9 activity used for genome editing. | PNAS Nexus | 2022 | https://conductscience.org/library/papers/36712324 | PubMed |
| 13 | 38260716 | Recent Advancements in Reducing the Off-Target Effect of CRISPR-Cas9 Genome Editing. | Biologics | 2024 | https://conductscience.org/library/papers/38260716 | PubMed |
| 14 | 27148179 | A Tet-on and Cre-loxP Based Genetic Engineering System for Convenient Recycling of Selection Markers in Penicillium oxalicum. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27148179 | PubMed |
| 15 | 27250768 | Genetically Engineered Phages: a Review of Advances over the Last Decade. | Microbiol Mol Biol Rev | 2016 | https://conductscience.org/library/papers/27250768 | PubMed |
| 16 | 22544021 | Full-length RecE enhances linear-linear homologous recombination and facilitates direct cloning for bioprospecting. | Nat Biotechnol | 2012 | https://conductscience.org/library/papers/22544021 | PubMed |
| 17 | 23656279 | Refactored M13 bacteriophage as a platform for tumor cell imaging and drug delivery. | ACS Synth Biol | 2012 | https://conductscience.org/library/papers/23656279 | PubMed |
| 18 | 36585118 | Direct cloning of a herpesvirus genome for rapid generation of infectious BAC clones. | J Adv Res | 2023 | https://conductscience.org/library/papers/36585118 | PubMed |
| 19 | 27254463 | RecET direct cloning and Redαβ recombineering of biosynthetic gene clusters, large operons or single genes for heterologous expression. | Nat Protoc | 2016 | https://conductscience.org/library/papers/27254463 | PubMed |
| 20 | 30763536 | Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. | Cell Host Microbe | 2019 | https://conductscience.org/library/papers/30763536 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| GP9 | 2815 | PubTator's text mining | https://conductscience.org/library/genes/2815 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41328409
GET https://conductscience.org/api/papers/v1/41328409/references?page=2